Built-in Culculator, CVVH, Filtration Fraction
Conditions
Brief summary
The goal of this observational study is to compare in ICU patients received CVVH treatment. The main questions it aims to answer are: Control of Filtration fraction by built-in calculator * Reduced filter clotting and prolong filter lifespan * Improve patient mortality Participants will divided into before group and after group based on the day when built-in calculator for calculating Filtration fraction was utilized. Researchers will compare before group to see if there were differences in clotting events, filter downtime, filter lifespan, mortality, etc.
Detailed description
\# built-in calculator for calculating Filtration fraction * The calculator was built in prescription system since 2020/10/01 * providing tempt filtration fraction for operators to adjust CVVH dose * the protocol of patient care didn't change between before and after group.
Interventions
DEVICEBuilt-in calculator to calculate Filtration fraction
A calculator built in electronic CVVH prescription system to calculate Filtration fraction
Sponsors
Taipei Medical University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* ICU patients received CVVH during 2019\ 2021 (3 years) in our hospital
Exclusion criteria
* under age of 20, pregnant, or with HIV infection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mortality | 30 days, 60 days, through study completion, an average of 1.5 year mortality in ICU and in Hospital | Patient death |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Filter lifespan | through the complete treatment course hours, an average of 24 hours | average treatment time per filter |
| electrolytes_1 | the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour) | — |
| electrolytes_2 | the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour) | K |
| electrolytes_3 | the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour) | Ca |
| electrolytes_4 | the last record received before CVVH (in an average of 1 hour), the first record received CVVH after 24 hours, the first record received after CVVH (in an average of 1 hour) | P |
| Filter clotting events | through the complete treatment course hours, an average of 24 hours | Filter clotting events |
| acid-base balance_2 | the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH) | bicarbonate |
| Filter downtime | through the complete treatment course hours, an average of 24 hours | downtime between filter replacement |
| others_1 | the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH) | body temperature |
| others_2 | the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH) | platelet |
| acid-base balance_1 | the last record received before CVVH (in an average of 1 hour before CVVH treatment), the first record received CVVH after 24 hours (in an average of 1 hour after CVVH treatment), the first record received after CVVH (in an average of 1 hour after CVVH) | pH |
Countries
Taiwan
Outcome results
None listed